¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2021³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2021-02-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2021³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2021-02-27
±³À°ÀÏÀÚ : 2021-02-27
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ 
±³À°ÁÖÁ¦ : 2021³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥      
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ  
´ã´çÀÚ : °¡¿Â
¿¬¶ôó : 02-2038-7988  
À̸ÞÀÏ : gaonpco@gaonpco.com      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 30¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í 1. »çÀüµî·Ï ȸ¿ø:¹«·áµî·Ï / ºñȸ¿ø:100,000¿ø / Àü°øÀÇ ¹× °£È£»ç: ¹«·áµî·Ï 2. ÇöÀåµî·Ï: ºÒ°¡      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ13:00~13:20 PC in Patients with CP or CPPS  ¾çÈñÁ¶(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ13:20~13:40 PC in Patients with BPH or Prostate Cancer  ¹ÚÁعé(±¹¸³°æÂûº´¿ø) 
Åä·Ð 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ13:40~14:00 Åä·Ð  Á¶¿ø¿­(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ14:00~14:20 ºñ´¢»ý½Ä±â °¨¿°ÀÇ ºÐÀÚÀ¯ÀüÇР À̹̰æ(Áß¾ÓÀÇ´ë) 
È޽Ġ02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ14:20~14:35 Coffee Break  () 
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ14:35~14:50 Guideline for the Management of Asymptomatic Bacteriuria  ½ÅÁÖÇö(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ14:50~15:05 The Role of Immunotherapy in Asymptomatic Bacteriuria  ÀÌÁ¤¿ì(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ15:05~15:20 The Role of Probiotics in Asymptomatic Bacteriuria  Á¶¼®(ÀÎÁ¦ÀÇ´ë) 
Åä·Ð 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ15:20~15:40 Åä·Ð  () 
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ15:40~15:55 Urological Management of HIV-Positive Patients  ÀÌÁÖ¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ15:55~16:10 COVID-19: Urological Manifestations, Viral RNA Detection and Special Considerations in Urological Conditions  ÃÖÁß¿ø(Áß¾Óº¸Èƺ´¿ø) 
Åä·Ð 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ16:10~16:25 Åä·Ð  ¹ÚÈïÀç(¼º±Õ°üÀÇ´ë) 
È޽Ġ02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ16:25~16:40 Coffee Break  () 
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ16:40~16:55 Antimicrobial Resistance of Neisseria Gonorrhoeae, Current State  Á¶ÀÎâ(±¹¸³°æÂûº´¿ø) 
±³À°½Ã°£ 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ16:55~17:10 Recent Updates of Male HPV Vaccination  ¹è»ó¶ô(°¡Å縯ÀÇ´ë) 
Åä·Ð 02¿ù 27ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀǽǠ17:10~17:30 Åä·Ð  Á¶¿µ»ï(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2021³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2021-02-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) Á¦32ȸ ¼­¶ó¹ú ¼Ò¾Æû¼Ò³â°ú Çмú´ëȸ : 2021-02-28
´ÙÀ½±Û ´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ (¿Â¶óÀÎ) 2021 School of Endocrine Surgeons : 2021-02-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
647 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-09 0 542 2018-08-29
646 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-08 0 564 2018-08-29
645 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-07 0 787 2018-08-29
644 ¼­¿ï ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø ´ëÇÑ°üÀý°æÇÐȸ Á¦9ȸ ¿¬¼ö°­Á : 2018-10-07 0 563 2018-08-29
643 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦ 18ȸ ºÎÀÎ¾Ï ½ÉÆ÷Áö¿ò : 2018-10-07 0 595 2018-08-29
642 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ÇÇÇмº ÀΰÝÀå¾Ö, ¿ì¿ï¼º ÀΰÝÀå¾Ö : 2018-10-06 0 1,070 2018-08-29
641 Àü³² 2018³â Á¦2Â÷ ÀÇ¿ø ¹× º´¿ø±Þ ÀÇ·á±â°ü ÇÁ·ÎÆ÷Æú ÁøÁ¤±³À° "ÀÇ»çÇùȸ ¹× °£È£Çùȸ ÀÎÁõ" : 2018-10-06 0 876 2018-08-29
640 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-06 0 433 2018-08-29
639 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hybrid Aortic Live Symposium : 2018-10-06 0 707 2018-08-29
638 °æ±â 2018 ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ½Å°æ°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-10-06 0 627 2018-08-29
637 ¼­¿ï 2018 Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2018-10-06 0 513 2018-08-29
636 ¼­¿ï Á¦38Â÷ ´ëÇÑ°üÀý°æÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-06 0 497 2018-08-29
635 °æ³² »ï¼ºÃ¢¿øº´¿ø 2018³â ¼º±Õ°ü´ëÇб³ SMC Changwon ½Å°æ¿Ü°úÇÐ ¿¬¼ö°­Á : 2018-10-06 0 986 2018-08-29
634 ÀÎõ 2018³â ÀÎÇϴ뺴¿ø ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-10-06 0 787 2018-08-29
633 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦11ȸ ¾Æ»ê±¹Á¦¼ÒÈ­±âº´½ÉÆ÷Áö¾ö(AIDDS) 2018 : 2018-10-06 0 579 2018-08-29
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷